Magnesium citrate

柠檬酸镁

Report date: 2024/04/01 17:58:14

Base Information

Drug NameMagnesium citrate
Drug Alias NameRMJH-111b
ClassificationSmall molecules > Inorganic and minerals salt
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Magnesium DeficiencyEssential Hypertension +[6] 
Global Approved IndicationsMagnesium Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustria
Original Approved Date1970/02/17
Country/TerritoryUnited StatesAustriaEgypt +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesRmj Holdings
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical CenterZagazig UniversityProtina Pharmazeutische Gmbh
Inactive CompaniesUniversity Of MinnesotaVanderbilt University Medical CenterRmj Holdings Llc
Active IndicationsMagnesium DeficiencyAsthmaOsteoporosis
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Essential HypertensionAtrial Premature Complexes

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG